Filing Details

Accession Number:
0001127602-10-002100
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-25 12:00:00
Reporting Period:
2010-01-22
Filing Date:
2010-01-25
Accepted Time:
2010-01-25 14:18:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410397 Stuart Grant 2190 Parkway Lake Drive
Birmingham AL 35244-
Sr Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-22 17,027 $7.02 9,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transacted under a 10b5-1 plan that was adopted on 11/23/09.